RETAIN Program for Work-related Injuries

(MN RETAIN Trial)

TG
SW
Overseen BySamantha Westphal, RN, BSN, PHN, CLMS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to evaluate how the RETAIN program (Minnesota Retaining Employment and Talent After Injury/Illness Network) can assist individuals in staying at work or returning to work after an injury or illness. Participants will either work with a dedicated case manager and access career resources or receive a job services handout. The trial is open to Minnesota residents who have been unable to work for at least four weeks due to a work-related or personal injury or illness. It is particularly suitable for those recently out of work and in need of job-related support. As an unphased trial, this study provides a unique opportunity for participants to access valuable support and resources to aid their return to work.

Will I have to stop taking my current medications?

The trial information does not specify whether you need to stop taking your current medications. It's best to discuss this with the trial coordinators or your healthcare provider.

What prior data suggests that the RETAIN program is safe for workforce retention and reduction of workplace disability?

Research shows that the RETAIN Program helps workers stay at or return to work after an injury or illness. It emphasizes early intervention, assisting people in returning to work as soon as it is safe. Studies have shown that these strategies improve outcomes for workers, enabling them to continue their jobs or find new ones if necessary.

As the program focuses on support and guidance rather than medical treatment, reports of physical side effects or negative reactions, common in drug trials, are absent. Instead, the program provides resources and case managers to assist workers in their return to work. This indicates the program is well-tolerated, offering support rather than medical interventions.12345

Why are researchers excited about this trial?

Researchers are excited about the RETAIN Program because it offers a personalized approach to helping individuals return to work after an injury. Unlike traditional methods that might only provide generic resources, this program assigns each participant a dedicated Return-to-Work Case Manager from Minnesota. This personalized support is supplemented with referrals to additional career and workforce development resources when needed, ensuring a comprehensive and tailored recovery pathway. This individualized attention could lead to more effective and faster reintegration into the workforce, which is why it holds promise compared to standard options.

What evidence suggests that the RETAIN Program is effective for improving workforce retention and reducing workplace disability?

Research has shown that the RETAIN Program helps workers return to their jobs or stay employed after an injury or illness. In this trial, participants in the Intervention Group will receive a dedicated Minnesota RETAIN Return-to-Work Case Manager and access to additional career and workforce development resources. Studies have found that the program's early support strategies can help keep people in their jobs and reduce future work-related disabilities. Early data suggests that people in the program use more services and have better job outcomes compared to those in the Control Group, who receive a handout with additional job-related services. Overall, the evidence supports the program's success in helping workers return to work sooner and remain employed.14567

Who Is on the Research Team?

LB

Laura Breeher, MD, MPH

Principal Investigator

Mayo Clinic

CC

Clayton Cowl, MD,MS

Principal Investigator

Mayo Clinic

Are You a Good Fit for This Trial?

The Minnesota RETAIN Phase 2 trial is for Minnesota residents who have had or will have surgery affecting their work within the last 12 weeks or next 8 weeks. Participants must have worked in MN at least one day in the past 3 months, be over 18, and employed or active in the labor force. It's not for those with worker's comp having a QRC/DCM, involved in related litigation, unable to consent, employed by certain organizations with return-to-work programs, or on SSDI/SSI.

Inclusion Criteria

Employed or currently in the labor force
Has worked at least one day within the last 3 months (80% or more of participants)
Has worked at least one day greater than 3 months but less than 6 months prior (up to 20% of participants)
See 3 more

Exclusion Criteria

Legal representation/litigation at the time of enrollment related to the medical condition
I am unable to understand and give consent for treatment.
I work for a RETAIN healthcare recipient with a return-to-work program.
See 2 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Intervention

Participants are assigned a dedicated Minnesota RETAIN Return-to-Work Case Manager and referred for additional career and workforce development resources as needed

12 months

Follow-up

Participants are monitored for workforce retention and reduction of workplace disability

12 months

Long-term Follow-up

Participants are monitored for long-term work disability reduction

5 years

What Are the Treatments Tested in This Trial?

Interventions

  • RETAIN Program
Trial Overview This study tests the RETAIN program aimed at helping employees stay at work or return after an injury or illness. It's a randomized control trial assessing if this program can reduce workplace disability and improve workforce retention through early intervention practices implemented by various partners including Mayo Clinic and state departments.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Active Control
Group I: Sub Study GroupExperimental Treatment1 Intervention
Group II: Intervention GroupExperimental Treatment1 Intervention
Group III: Control GroupActive Control1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Mayo Clinic

Lead Sponsor

Trials
3,427
Recruited
3,221,000+

Minnesota Department of Employment and Economic Development

Collaborator

Trials
1
Recruited
5,200+

Minnesota Department of Health

Collaborator

Trials
9
Recruited
179,000+

Mathematica Policy Research

Collaborator

Trials
1
Recruited
5,200+

United States Department of Labor

Collaborator

Trials
1
Recruited
5,200+

Minnesota Department of Labor and Industry

Collaborator

Trials
1
Recruited
5,200+

United States Social Security Administration

Collaborator

Trials
2
Recruited
8,200+

Workforce Development, Inc.

Collaborator

Trials
2
Recruited
8,400+

Published Research Related to This Trial

In the Ontario Life After Workplace Injury Study, 40% of eligible workers with work-related injuries participated in an 18-month follow-up, revealing that 61% were still employed by their original employer, while 23% were not working at all.
Preliminary data showed that longer durations of disability claims were associated with poorer health outcomes and function, highlighting the need for targeted interventions to support these workers' recovery and return to work.
Cohort profile: the Ontario Life After Workplace Injury Study (OLAWIS).Mustard, C., Nadalin, V., Carnide, N., et al.[2021]
The Vocational Improvement Project, a 5.5-year pilot program in Washington State, successfully reduced repeat referrals and delays in vocational rehabilitation for injured workers, while also increasing worker choice and establishing partnerships to enhance outcomes.
Despite these improvements, challenges remain, as retraining plan completion rates are below 60% and only half of the workers earned wages within two years after completing their plans, indicating a need for further enhancements in the program.
Improving vocational rehabilitation services for injured workers in Washington State.Sears, JM., Wickizer, TM., Schulman, BA.[2022]
The articles highlight the potential for early intervention strategies to help workers with medical conditions avoid prolonged work disability, based on analyses of disability claims data and case studies from 50 employers.
By improving systems to identify and support these workers promptly, stakeholders can significantly influence their job retention and overall outcomes, suggesting a need for evidence-based interventions in the workplace.
Opportunities for Early Intervention to Avoid Prolonged Work Disability: Introduction to the Special Section.Ben-Shalom, Y., Schimmel Hyde, J.[2019]

Citations

1.mnretain.commnretain.com/
Home - MN RETAINThe Retaining Employment and Talent after Injury/Illness Network (RETAIN) helps workers stay at or return to work when an injury or illness impacts employment.
The Retaining Employment and Talent After Injury/Illness ...This report presents the five RETAIN programs' early impacts on enrollee service use, employment, and health; it is the first of two reports on ...
The MN Retain Study - Minnesota Physician April 2025 IssueThe Minnesota RETAIN program's primary goal is to provide early intervention strategies for workers to stay at work or return to work as soon as medically ...
Mn RETAIN: An early intervention model to identify and ...MN RETAIN collects numerous data points to help evaluate the effectiveness of the intervention. Included among these data are demographic ...
NCT05146349 | Minnesota RETAIN Impact EvaluationThis study is a randomized control trial (RCT) to evaluate the impact of RETAIN program expansion and services on workforce retention and reduction of future ...
Minnesota RETAINMinnesota RETAIN aims to help workers return to work after injury/illness, and assists those who cannot be accommodated in their regular job.
Retaining Employment and Talent After Injury/Illness ...RETAIN programs implement early intervention strategies to improve stay-at-work/return-to-work (SAW/RTW) outcomes of individuals who experience a work ...
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security